LORI TARVER: Open Payments
NPI 1477201002 · MOSS BLUFF, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 14 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $87 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $199 |
| ABBVIE INC. | 3 | $49 |
| Dexcom, Inc. | 2 | $41 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $15 |
Products named: AIRSUPRA, FARXIGA, BREZTRI, Dexcom G6 Transmitter, UBRELVY, QULIPTA, Auvelity, VOQUEZNA.
Industry payments across LA — which companies pay providers there.
